ArticleKidney medicine2024

Empagliflozin and Rapid Kidney Function Decline Incidence in Type 2 Diabetes: An Exploratory Analysis From the EMPA-REG OUTCOME Trial.

Samy Hadjadj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.